Found: 22
Select item for more details and to access through your institution.
Efficacy of Helicobater pylori eradication in patients with diffuse large B‐cell lymphoma of the stomach: A systematic review.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 6, p. 643, doi. 10.1111/ejh.13871
- By:
- Publication type:
- Article
The incidence, complications, and treatment of iron deficiency in pregnancy.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 6, p. 633, doi. 10.1111/ejh.13870
- By:
- Publication type:
- Article
von Willebrand factor activity levels are influenced by driver mutation status in polycythemia vera and essential thrombocythemia patients with well‐controlled platelet counts.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 6, p. 779, doi. 10.1111/ejh.13866
- By:
- Publication type:
- Article
Clinical view versus guideline adherence in ferritin monitoring and initiating iron chelation therapy in patients with myelodysplastic syndromes.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 6, p. 772, doi. 10.1111/ejh.13865
- By:
- Publication type:
- Article
Contemporary evaluation of acute myeloid leukemia patients with long‐term survival exceeding 5 years.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 6, p. 765, doi. 10.1111/ejh.13864
- By:
- Publication type:
- Article
5′‐nucleotidase, cytosolic II genotype, and clinical outcome in patients with acute myeloid leukemia with intermediate‐risk cytogenetics.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 6, p. 755, doi. 10.1111/ejh.13862
- By:
- Publication type:
- Article
Conditioning with melphalan 200 mg/m<sup>2</sup> and subsequent ASCT improves progression‐free and overall survival in elderly myeloma patients compared to standard of care.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 6, p. 749, doi. 10.1111/ejh.13861
- By:
- Publication type:
- Article
Advanced clinical parameters: A complementary hydroxyurea adherence evaluation in sickle cell anemia treatment.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 6, p. 736, doi. 10.1111/ejh.13860
- By:
- Publication type:
- Article
JAK inhibition with ruxolitinib in relapsed or refractory classical Hodgkin lymphoma: Final results of a phase II, open label, multicentre clinical trial (JeRiCHO).
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 6, p. 728, doi. 10.1111/ejh.13859
- By:
- Publication type:
- Article
Ibrutinib as a treatment of hematologic autoimmune disorders in patients with indolent B‐cell lymphoma.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 6, p. 719, doi. 10.1111/ejh.13858
- By:
- Publication type:
- Article
A comparison of four leukapheresis methods to harvest an optimal dose of CD34+ cells: A single center experience.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 6, p. 711, doi. 10.1111/ejh.13856
- By:
- Publication type:
- Article
COVID‐19: Vaccine‐induced immune thrombotic thrombocytopenia.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 6, p. 619, doi. 10.1111/ejh.13855
- By:
- Publication type:
- Article
The safety of Bruton's tyrosine kinase inhibitors in B‐cell malignancies: A systematic review.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 6, p. 696, doi. 10.1111/ejh.13854
- By:
- Publication type:
- Article
Changes in body mass index during treatment of childhood acute lymphoblastic leukemia with the Nordic ALL2008 protocol.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 6, p. 656, doi. 10.1111/ejh.13848
- By:
- Publication type:
- Article
Upregulation of microRNA‐597 in myelodysplastic syndromes induces apoptosis through FOSL2 inhibition.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 6, p. 680, doi. 10.1111/ejh.13852
- By:
- Publication type:
- Article
CAR‐T cell therapy for patients with hematological malignancies. A systematic review.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 6, p. 601, doi. 10.1111/ejh.13851
- By:
- Publication type:
- Article
Patient age and donor HLA matching can stratify allogeneic hematopoietic cell transplantation patients into prognostic groups.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 6, p. 672, doi. 10.1111/ejh.13850
- By:
- Publication type:
- Article
Luspatercept, a two‐edged sword in beta‐thalassemia‐associated paravertebral extramedullary hematopoietic masses (EHMs).
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 6, p. 664, doi. 10.1111/ejh.13849
- By:
- Publication type:
- Article
Activated prothrombin complex concentrate to treat bleeding events in acquired hemophilia A: BAHAS study.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 6, p. 686, doi. 10.1111/ejh.13853
- By:
- Publication type:
- Article
The role of opportunistic quantitative computed tomography in the evaluation of bone disease and risk of fracture in thalassemia major.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 6, p. 648, doi. 10.1111/ejh.13847
- By:
- Publication type:
- Article
Assessment of mononuclear cell populations derived from human umbilical cord blood.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 6, p. 787, doi. 10.1111/ejh.13846
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 6, p. 599, doi. 10.1111/ejh.13662
- Publication type:
- Article